ESMO Guides for Patients: Disclaimer and declaration of interest

Disclaimer

ESMO Guides for Patients are prepared in collaboration with the Anticancer Fund as a service to patients, to help patients and their relatives better understand the nature of their cancer type and understand the best treatment choices available. Please note that information in these Guides for Patients does not replace a medical consultation. ESMO recommends that patients ask their doctors about what tests or types of treatments are needed for their type and stage of disease.

Patient information based on the ESMO Clinical Practice Guidelines - Conflict of interest disclosures

  • William Allum: No conflicts of interest to declare
  • Dirk Arnold: Research grants – Roche, Sanofi
  • Michele Baccarani: Honoraria from Novartis, Bristol-Myers Squibb, Pfizer and Ariad for participation to advisory boards and as a speaker at scientific and educational meetings.
  • Greet Boland: No conflicts of interest to declare
  • Gauthier Bouche: No conflicts of interest to declare
  • Joaquim Bellmunt: Consultant or Advisory Role - Lilly, Pierre Fabre and Sanofi Aventis
  • An Billiau: Medical writer of Celsus Medical Writing LLC. – Honoraria from Anticancer Fund
  • Stefano Cascinu: No conflicts of interest to declare
  • Raphael Catane: No conflicts of interest to declare
  • Nicoletta Colombo: No conflicts of interest to declare
  • Lucio Crinò: No conflicts of interest to declare
  • David Cunningham: Research funding - Roche and Amgen
  • Giannicola D’Addario: No conflicts of interest to declare
  • Louis Denis: No conflicts of interest to declare
  • Martin Dreyling: Consultancy/Honoraria: Celgene, Janssen, Mundipharma, Pfizer, Roche; Research funding to the institution: Celgene, Janssen, Pfizer, Mundipharma, Roche.
  • Reinhard Dummer: Research funding - Astra Zeneca, Novartis, Cephalon, Merck Sharp & Dhome, Transgene, Bristol-Myers Squibb, Roche, GlaxoSmith Klein, Bayer; Consultant or Advisory Board: Astra Zeneca, Novartis, Cephalon, Merck Sharp & Dhome, Transgene, Genta, Bayer, Roche, Bristol-Myers Squibb, GlaxoSmith Klein, Spirig.
  • Enriqueta Felip: Consultancy/Honoraria – Ely Lilly, GlaxoSmith Klein, Pfizer, Roche, Boehringer Ingelheim
  • Martin Fey: No conflicts of interest to declare
  • Ivan Gardini: No conflicts of interest to declare
  • Jan Geissler: No disclosure at time of going online
  • Glimelius Bengt: No conflicts of interest to declare
  • Magdalena Grce: No conflicts of interest to declare
  • Christine Haie-Meder: No conflicts of interest to declare
  • Alan Horwich: His institution is inventor of abiraterone and receives royalty payments; no personal conflicts of interest
  • Svetislav Jelic: No conflicts of interest to declare
  • Anna Jewel: No conflicts of interest to declare
  • Svetlana Jezdic: No conflicts of interest to declare
  • Lorenz Jost: No conflicts of interest to declare
  • Holbrook Khort: No conflicts of interest to declare
  • David Kirby: No conflicts of interest to declare
  • Gabriella Kornek: No disclosure at time of going online
  • Paris Kosmidis: No conflicts of interest to declare
  • Stella Kyriakides: No conflicts of interest to declare
  • Roberto Labianca: Research grants – Roche, Sanofi
  • Giulio Metro: Honoraria from Anticancer Fund
  • Annemie Michiels: No conflicts of interest to declare
  • Alicia Okines: Honorarium and travel support - Roche
  • Ruth Payne: No conflicts of interest to declare
  • George Pentheroudakis: No conflicts of interest to declare
  • Bernhard Pestalozzi: No conflicts of interest to declare
  • Martine Piccart: Grant - Boehringer-Ingelheim, Bristol-Myers Squibb, Glaxo Smith Kline, Novartis, Pfizer; Roche, Merck; Consultant – Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Roche; Advisory Board - PharmaMar
  • George Plataniotis: No conflicts of interest to declare
  • Simonetta Rapetti: No disclosure at time of going online
  • Cristiana Sessa: No conflicts of interest to declare
  • Thomas Seufferlein: No conflicts of interest to declare
  • Michael Stahl: No conflicts of interest to declare
  • Ana Ugarte: No conflicts of interest to declare
  • Stefania Vallone: No conflicts of interest to declare
  • Eric Van Cutsem: Research funding – Amgen, MerckSerono, Pfizer, Roche, Sanofi-Aventis
  • Hilje van der Grient-Logtenberg: No conflicts of interest to declare
  • Ingo van Thiel: No conflicts of interest to declare
  • Chris Verslype: Research funding – Bayer, Sirtex, Novartis